Want to see ANIX full AI Analyst Report?
Anixa Biosciences (ANIX) Income Statement
Anixa Biosciences Income Statement
Last quarter (Q3 2026), Anixa Biosciences's total revenue was $0.00. In Q3, Anixa Biosciences's net income was $-2.61M. See Anixa Biosciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Oct 25 | Oct 24 | Oct 23 | Oct 22 | Oct 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 210.00K | $ 0.00 | $ 512.00K | |
| $ -36.00K | $ -37.00K | $ 49.00K | $ 0.00 | $ 127.00K | |
| $ 11.66M | $ 13.83M | $ 11.06M | $ 13.88M | $ 13.26M | |
| Depreciation and Amortization | $ 36.00K | $ 37.00K | $ 46.00K | $ 42.00K | $ 59.86K |
| $ -10.99M | $ -12.66M | $ -9.88M | $ -13.73M | $ -13.08M | |
| $ -11.70M | $ -13.83M | $ -11.01M | $ -13.88M | $ -13.14M | |
| $ 673.00K | $ 1.13M | $ 1.08M | $ 104.00K | $ 7.77K | |
| $ -11.03M | $ -12.70M | $ -9.93M | $ -13.77M | $ -13.13M | |
| $ -10.93M | $ -12.55M | $ -9.81M | $ -13.60M | $ -12.95M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.34 | $ -0.39 | $ -0.32 | $ -0.45 | $ -0.45 |
| Diluted EPS | $ -0.34 | $ -0.39 | $ -0.32 | $ -0.45 | $ -0.45 |
| Weighted Average Shares Outstanding | 32.45M | 31.90M | 30.98M | 30.37M | 28.58M |
| Weighted Average Shares Outstanding (Diluted) | 32.45M | 31.90M | 30.98M | 30.37M | 28.58M |
Currency in USD
